PubRank

Erwin W Gelfand

Author PubWeight™ 145.43‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines. Nat Rev Drug Discov 2008 2.45
2 Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids. Hum Mol Genet 2004 2.14
3 Particulate levels are associated with early asthma worsening in children with persistent disease. Am J Respir Crit Care Med 2006 2.11
4 Spontaneous airway hyperresponsiveness in estrogen receptor-alpha-deficient mice. Am J Respir Crit Care Med 2006 1.86
5 Effector CD8+ T cells mediate inflammation and airway hyper-responsiveness. Nat Med 2004 1.71
6 Estrogen determines sex differences in airway responsiveness after allergen exposure. Am J Respir Cell Mol Biol 2007 1.63
7 Naturally occurring lung CD4(+)CD25(+) T cell regulation of airway allergic responses depends on IL-10 induction of TGF-beta. J Immunol 2007 1.63
8 The enhancement or prevention of airway hyperresponsiveness during reinfection with respiratory syncytial virus is critically dependent on the age at first infection and IL-13 production. J Immunol 2005 1.56
9 Different potentials of gamma delta T cell subsets in regulating airway responsiveness: V gamma 1+ cells, but not V gamma 4+ cells, promote airway hyperreactivity, Th2 cytokines, and airway inflammation. J Immunol 2004 1.50
10 The role of IL-13 in established allergic airway disease. J Immunol 2002 1.48
11 A comparison of the clinical characteristics of children and adults with severe asthma. Chest 2003 1.42
12 Interleukin-1 receptor antagonist attenuates airway hyperresponsiveness following exposure to ozone. Am J Respir Cell Mol Biol 2004 1.36
13 The effects of airway microbiome on corticosteroid responsiveness in asthma. Am J Respir Crit Care Med 2013 1.36
14 Importance of the personal endotoxin cloud in school-age children with asthma. J Allergy Clin Immunol 2005 1.33
15 Distribution and leukocyte contacts of gammadelta T cells in the lung. J Leukoc Biol 2005 1.30
16 Insights into the pathogenesis of asthma utilizing murine models. Int Arch Allergy Immunol 2004 1.30
17 Contribution of antigen-primed CD8+ T cells to the development of airway hyperresponsiveness and inflammation is associated with IL-13. J Immunol 2004 1.30
18 MEK kinase 2 and the adaptor protein Lad regulate extracellular signal-regulated kinase 5 activation by epidermal growth factor via Src. Mol Cell Biol 2003 1.29
19 V gamma 4+ gamma delta T cells regulate airway hyperreactivity to methacholine in ovalbumin-sensitized and challenged mice. J Immunol 2003 1.25
20 Mast cells, Fc epsilon RI, and IL-13 are required for development of airway hyperresponsiveness after aerosolized allergen exposure in the absence of adjuvant. J Immunol 2004 1.23
21 MHC class I-dependent Vgamma4+ pulmonary T cells regulate alpha beta T cell-independent airway responsiveness. Proc Natl Acad Sci U S A 2002 1.23
22 IFN-gamma production during initial infection determines the outcome of reinfection with respiratory syncytial virus. Am J Respir Crit Care Med 2007 1.22
23 Jagged1 on dendritic cells and Notch on CD4+ T cells initiate lung allergic responsiveness by inducing IL-4 production. J Immunol 2009 1.21
24 The G glycoprotein of respiratory syncytial virus depresses respiratory rates through the CX3C motif and substance P. J Virol 2003 1.20
25 Leukotriene B4 receptor-1 is essential for allergen-mediated recruitment of CD8+ T cells and airway hyperresponsiveness. J Immunol 2005 1.18
26 Is forced expiratory volume in one second the best measure of severity in childhood asthma? Am J Respir Crit Care Med 2004 1.15
27 Factor B of the alternative complement pathway regulates development of airway hyperresponsiveness and inflammation. Proc Natl Acad Sci U S A 2006 1.14
28 Requirement for leukotriene B4 receptor 1 in allergen-induced airway hyperresponsiveness. Am J Respir Crit Care Med 2005 1.13
29 The leukotriene B4 receptor (BLT1) is required for effector CD8+ T cell-mediated, mast cell-dependent airway hyperresponsiveness. J Immunol 2006 1.12
30 Airway hyperresponsiveness through synergy of gammadelta} T cells and NKT cells. J Immunol 2007 1.11
31 Syk activation in dendritic cells is essential for airway hyperresponsiveness and inflammation. Am J Respir Cell Mol Biol 2005 1.10
32 Migration and accumulation of eosinophils toward regional lymph nodes after airway allergen challenge. J Allergy Clin Immunol 2004 1.10
33 The role of leukotriene B(4) in allergic diseases. Allergol Int 2008 1.09
34 The response of children with asthma to ambient particulate is modified by tobacco smoke exposure. Am J Respir Crit Care Med 2011 1.09
35 Quantitative computed tomography detects peripheral airway disease in asthmatic children. Pediatr Pulmonol 2005 1.07
36 Virus-induced airway dysfunction: pathogenesis and biomechanisms. Pediatr Infect Dis J 2005 1.06
37 Essential role of Notch signaling in effector memory CD8+ T cell-mediated airway hyperresponsiveness and inflammation. J Exp Med 2008 1.05
38 Hepatocyte growth factor attenuates airway hyperresponsiveness, inflammation, and remodeling. Am J Respir Cell Mol Biol 2004 1.05
39 IKBKG (nuclear factor-kappa B essential modulator) mutation can be associated with opportunistic infection without impairing Toll-like receptor function. J Allergy Clin Immunol 2008 1.03
40 A randomized trial to test the effectiveness of art therapy for children with asthma. J Allergy Clin Immunol 2010 1.03
41 Complement activation is critical to airway hyperresponsiveness after acute ozone exposure. Am J Respir Crit Care Med 2003 1.03
42 Virus-specific IgE enhances airway responsiveness on reinfection with respiratory syncytial virus in newborn mice. J Allergy Clin Immunol 2008 1.03
43 Animal models of airway sensitization. Curr Protoc Immunol 2007 1.02
44 Importance of myeloid dendritic cells in persistent airway disease after repeated allergen exposure. Am J Respir Crit Care Med 2005 1.02
45 Do NHLBI lung function criteria apply to children? A cross-sectional evaluation of childhood asthma at National Jewish Medical and Research Center, 1999-2002. Pediatr Pulmonol 2005 1.02
46 Plasticity of regulatory T cells: subversion of suppressive function and conversion to enhancement of lung allergic responses. J Immunol 2008 1.02
47 IL-13 is essential to the late-phase response in allergic rhinitis. J Allergy Clin Immunol 2006 1.01
48 Inhibition of spleen tyrosine kinase prevents mast cell activation and airway hyperresponsiveness. Am J Respir Crit Care Med 2005 1.01
49 CD8+ T cell-mediated airway hyperresponsiveness and inflammation is dependent on CD4+IL-4+ T cells. J Immunol 2007 1.01
50 The failure of interleukin-10-deficient mice to develop airway hyperresponsiveness is overcome by respiratory syncytial virus infection in allergen-sensitized/challenged mice. Am J Respir Crit Care Med 2002 1.00
51 Surfactant protein D regulates airway function and allergic inflammation through modulation of macrophage function. Am J Respir Crit Care Med 2003 1.00
52 A novel mutation in NFKBIA/IKBA results in a degradation-resistant N-truncated protein and is associated with ectodermal dysplasia with immunodeficiency. Hum Mutat 2008 0.99
53 Responsiveness to respiratory syncytial virus in neonates is mediated through thymic stromal lymphopoietin and OX40 ligand. J Allergy Clin Immunol 2012 0.99
54 Pirfenidone modulates airway responsiveness, inflammation, and remodeling after repeated challenge. Am J Respir Cell Mol Biol 2006 0.99
55 Role of the LTB4/BLT1 pathway in allergen-induced airway hyperresponsiveness and inflammation. Allergol Int 2006 0.99
56 Understanding asthma using animal models. Allergy Asthma Immunol Res 2009 0.99
57 Evidence that CD8+ dendritic cells enable the development of gammadelta T cells that modulate airway hyperresponsiveness. J Immunol 2008 0.98
58 Estimating effects of ambient PM(2.5) exposure on health using PM(2.5) component measurements and regression calibration. J Expo Sci Environ Epidemiol 2006 0.98
59 Modulation of p53 activity by IkappaBalpha: evidence suggesting a common phylogeny between NF-kappaB and p53 transcription factors. BMC Immunol 2005 0.97
60 Histopathology of severe childhood asthma: a case series. Chest 2003 0.97
61 Vgamma1+ T cells and tumor necrosis factor-alpha in ozone-induced airway hyperresponsiveness. Am J Respir Cell Mol Biol 2008 0.96
62 Mismatched antigen prepares gamma delta T cells for suppression of airway hyperresponsiveness. J Immunol 2005 0.96
63 IL-10-treated dendritic cells decrease airway hyperresponsiveness and airway inflammation in mice. J Allergy Clin Immunol 2007 0.96
64 Pro: mice are a good model of human airway disease. Am J Respir Crit Care Med 2002 0.95
65 Effect of microbial heat shock proteins on airway inflammation and hyperresponsiveness. J Immunol 2002 0.94
66 Inhibition of complement activation decreases airway inflammation and hyperresponsiveness. Am J Respir Crit Care Med 2003 0.94
67 Antigen specificity is not required for modulation of lung allergic responses by naturally occurring regulatory T cells. J Immunol 2009 0.94
68 NF-kappaB-dependent induction of cathelicidin-related antimicrobial peptide in murine mast cells by lipopolysaccharide. Int Arch Allergy Immunol 2009 0.94
69 Leukotriene B4 release from mast cells in IgE-mediated airway hyperresponsiveness and inflammation. Am J Respir Cell Mol Biol 2008 0.93
70 Vaccine-induced CD8+ T cell-dependent suppression of airway hyperresponsiveness and inflammation. J Immunol 2009 0.93
71 Transient neutrophil infiltration after allergen challenge is dependent on specific antibodies and Fc gamma III receptors. J Immunol 2003 0.93
72 Intravenous immunoglobulin: properties, mode of action and practical use in dermatology. Acta Derm Venereol 2007 0.93
73 Corticosteroids enhance CD8+ T cell-mediated airway hyperresponsiveness and allergic inflammation by upregulating leukotriene B4 receptor 1. J Allergy Clin Immunol 2008 0.93
74 Urine leukotriene E4 levels are associated with decreased pulmonary function in children with persistent airway obstruction. J Allergy Clin Immunol 2006 0.92
75 RANTES (CCL5) regulates airway responsiveness after repeated allergen challenge. Am J Respir Cell Mol Biol 2006 0.92
76 Effect of chemically modified IL-13 short interfering RNA on development of airway hyperresponsiveness in mice. J Allergy Clin Immunol 2007 0.92
77 Leukotriene B4 receptor 1 expression on dendritic cells is required for the development of Th2 responses and allergen-induced airway hyperresponsiveness. J Immunol 2008 0.92
78 Adoptive transfer of T cells induces airway hyperresponsiveness independently of airway eosinophilia but in a signal transducer and activator of transcription 6-dependent manner. J Allergy Clin Immunol 2002 0.92
79 Expression of functional activating and inhibitory Fcgamma receptors on human B cells. Int Arch Allergy Immunol 2004 0.92
80 Critical role of the Fc receptor gamma-chain on APCs in the development of allergen-induced airway hyperresponsiveness and inflammation. J Immunol 2007 0.91
81 IL-17A is essential to the development of elastase-induced pulmonary inflammation and emphysema in mice. Respir Res 2013 0.91
82 Alteration of airway neuropeptide expression and development of airway hyperresponsiveness following respiratory syncytial virus infection. Am J Physiol Lung Cell Mol Physiol 2004 0.91
83 SLAP deficiency enhances number and function of regulatory T cells preventing chronic autoimmune arthritis in SKG mice. J Immunol 2011 0.91
84 Peanut-induced intestinal allergy is mediated through a mast cell-IgE-FcepsilonRI-IL-13 pathway. J Allergy Clin Immunol 2010 0.91
85 Cyclin-dependent kinase 6 inhibits proliferation of human mammary epithelial cells. Mol Cancer Res 2004 0.91
86 Low-dose lipopolysaccharide affects lung allergic responses by regulating Jagged1 expression on antigen-pulsed dendritic cells. Int Arch Allergy Immunol 2011 0.90
87 The role of virus-specific immunoglobulin E in airway hyperresponsiveness. Am J Respir Crit Care Med 2004 0.90
88 Loss of T regulatory cell suppression following signaling through glucocorticoid-induced tumor necrosis receptor (GITR) is dependent on c-Jun N-terminal kinase activation. J Biol Chem 2012 0.90
89 Inhibition of early airway neutrophilia does not affect development of airway hyperresponsiveness. Am J Respir Cell Mol Biol 2004 0.90
90 IL-2 and IL-18 attenuation of airway hyperresponsiveness requires STAT4, IFN-gamma, and natural killer cells. Am J Respir Cell Mol Biol 2006 0.90
91 Exposure to tobacco smoke increases leukotriene E4-related albuterol usage and response to montelukast. J Allergy Clin Immunol 2008 0.90
92 Respiratory syncytial virus-induced airway hyperresponsiveness is independent of IL-13 compared with that induced by allergen. J Allergy Clin Immunol 2003 0.89
93 Activation of naturally occurring lung CD4(+)CD25(+) regulatory T cells requires CD8 and MHC I interaction. Proc Natl Acad Sci U S A 2007 0.89
94 Mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2-dependent pathways are essential for CD8+ T cell-mediated airway hyperresponsiveness and inflammation. J Allergy Clin Immunol 2009 0.89
95 Effects of wintertime ambient air pollutants on asthma exacerbations in urban minority children with moderate to severe disease. J Allergy Clin Immunol 2004 0.89
96 Prior airway exposure to allergen increases virus-induced airway hyperresponsiveness. J Allergy Clin Immunol 2003 0.88
97 A novel prostacyclin agonist protects against airway hyperresponsiveness and remodeling in mice. Am J Respir Cell Mol Biol 2012 0.88
98 Mouse models of allergic diseases. Curr Opin Immunol 2009 0.88
99 Reversal of allergic airway hyperreactivity after long-term allergen challenge depends on gammadelta T cells. Am J Respir Crit Care Med 2003 0.88
100 Calcitonin gene-related peptide: role in airway homeostasis. Curr Opin Pharmacol 2004 0.87
101 Regulation of airway hyperresponsiveness by calcitonin gene-related peptide in allergen sensitized and challenged mice. Am J Respir Crit Care Med 2002 0.86
102 Allergic airway hyperresponsiveness-enhancing gammadelta T cells develop in normal untreated mice and fail to produce IL-4/13, unlike Th2 and NKT cells. J Immunol 2009 0.86
103 Immunoglobulin replacement therapy in primary antibody deficiency diseases--maximizing success. Int Arch Allergy Immunol 2005 0.86
104 Physiologic assessment of allergic rhinitis in mice: role of the high-affinity IgE receptor (FcepsilonRI). J Allergy Clin Immunol 2005 0.86
105 Successful school-based intervention for inner-city children with persistent asthma. J Asthma 2004 0.85
106 CD8 regulates T regulatory cell production of IL-6 and maintains their suppressive phenotype in allergic lung disease. J Immunol 2010 0.85
107 The critical role of complement alternative pathway regulator factor H in allergen-induced airway hyperresponsiveness and inflammation. J Immunol 2011 0.85
108 Montelukast during primary infection prevents airway hyperresponsiveness and inflammation after reinfection with respiratory syncytial virus. Am J Respir Crit Care Med 2010 0.85
109 Induction of regulated upon activation, normal T cells expressed and secreted (RANTES) and transforming growth factor-beta 1 in airway epithelial cells by Mycoplasma pneumoniae. Am J Respir Cell Mol Biol 2003 0.85
110 Growth factors temporally associate with airway responsiveness and inflammation in allergen-exposed mice. Int Arch Allergy Immunol 2007 0.84
111 Sequential engagement of FcεRI on Mast Cells and Basophil Histamine H(4) Receptor and FcεRI in Allergic Rhinitis. J Immunol 2012 0.84
112 Intravenous immune globulin in autoimmune and inflammatory diseases. N Engl J Med 2013 0.84
113 Susceptibility to vaccinia virus infection and spread in mice is determined by age at infection, allergen sensitization and mast cell status. Int Arch Allergy Immunol 2012 0.83
114 Identification of multiple cell cycle regulatory functions of p57Kip2 in human T lymphocytes. J Immunol 2004 0.83
115 Inhibition of neutrophil elastase attenuates airway hyperresponsiveness and inflammation in a mouse model of secondary allergen challenge: neutrophil elastase inhibition attenuates allergic airway responses. Respir Res 2013 0.83
116 Ozone increases airway hyperreactivity and mucus hyperproduction in mice previously exposed to allergen. J Toxicol Environ Health A 2010 0.83
117 Differential effects of dendritic cell transfer on airway hyperresponsiveness and inflammation. Am J Respir Cell Mol Biol 2009 0.83
118 The Role of RSV Infection in Asthma Initiation and Progression: Findings in a Mouse Model. Pulm Med 2011 0.83
119 Protein kinase C alpha, betaI, and betaII isozymes regulate cytokine production in mast cells through MEKK2/ERK5-dependent and -independent pathways. Cell Immunol 2006 0.83
120 Allergen-specific early neutrophil infiltration after allergen challenge in a murine model. Chest 2003 0.82
121 Stepwise epigenetic and phenotypic alterations poise CD8+ T cells to mediate airway hyperresponsiveness and inflammation. J Immunol 2013 0.82
122 Plasticity of invariant NKT cell regulation of allergic airway disease is dependent on IFN-gamma production. J Immunol 2010 0.82
123 Requirement for the p75 TNF-alpha receptor 2 in the regulation of airway hyperresponsiveness by gamma delta T cells. J Immunol 2002 0.82
124 The steroidogenic enzyme Cyp11a1 is essential for development of peanut-induced intestinal anaphylaxis. J Allergy Clin Immunol 2013 0.82
125 Blocking the leukotriene B4 receptor 1 inhibits late-phase airway responses in established disease. Am J Respir Cell Mol Biol 2011 0.82
126 Arhgef1 is required by T cells for the development of airway hyperreactivity and inflammation. Am J Respir Crit Care Med 2007 0.81
127 Airway hyperresponsiveness in the absence of CD4+ T cells after primary but not secondary challenge. Am J Respir Cell Mol Biol 2005 0.81
128 MEF2C regulates c-Jun but not TNF-alpha gene expression in stimulated mast cells. Eur J Immunol 2003 0.81
129 Steroidogenic enzyme Cyp11a1 regulates Type 2 CD8+ T cell skewing in allergic lung disease. Proc Natl Acad Sci U S A 2013 0.81
130 Inhibition of Pim1 kinase activation attenuates allergen-induced airway hyperresponsiveness and inflammation. Am J Respir Cell Mol Biol 2011 0.81
131 Aerosolized anti-T-cell-receptor antibodies are effective against airway inflammation and hyperreactivity. Int Arch Allergy Immunol 2004 0.81
132 NGF rescues human B lymphocytes from anti-IgM induced apoptosis by activation of PKCzeta. Eur J Immunol 2002 0.80
133 Are all IGIVs the same? J Allergy Clin Immunol 2002 0.80
134 Requirement for chemokine receptor 5 in the development of allergen-induced airway hyperresponsiveness and inflammation. Am J Respir Cell Mol Biol 2011 0.80
135 Inhibition of Pim1 kinase prevents peanut allergy by enhancing Runx3 expression and suppressing T(H)2 and T(H)17 T-cell differentiation. J Allergy Clin Immunol 2012 0.79
136 Effect of montelukast on peripheral airflow obstruction in children with asthma. Ann Allergy Asthma Immunol 2006 0.79
137 Serum levels of surfactant protein D are increased in mice with lung tumors. Cancer Res 2003 0.79
138 Urinary leukotriene E₄ levels identify children with tobacco smoke exposure at risk for asthma exacerbation. J Allergy Clin Immunol 2011 0.79
139 Contribution of allergen-specific and nonspecific nasal responses to early-phase and late-phase nasal responses. J Allergy Clin Immunol 2007 0.79
140 Effects of anti-g and anti-f antibodies on airway function after respiratory syncytial virus infection. Am J Respir Cell Mol Biol 2014 0.78
141 Microbial heat shock protein 65 attenuates airway hyperresponsiveness and inflammation by modulating the function of dendritic cells. J Immunol 2012 0.78
142 Targeting CXCR3 reduces ligand-induced T-cell activation but not development of lung allergic responses. Ann Allergy Asthma Immunol 2011 0.77
143 Emphysema requires the receptor for advanced glycation end-products triggering on structural cells. Am J Respir Cell Mol Biol 2015 0.76
144 Coding-region alterations in BTK do not universally cause X-linked agammaglobulinemia. J Allergy Clin Immunol 2013 0.76
145 The Atopic Dermatitis Quickscore (ADQ): validation of a new parent-administered atopic dermatitis scoring tool. Ann Allergy Asthma Immunol 2008 0.76
146 Diagnosis and evaluation of primary panhypogammaglobulinemia: a molecular and genetic challenge. J Allergy Clin Immunol 2013 0.75
147 Targeting Pim1 kinase in the treatment of peanut allergy. Expert Opin Ther Targets 2013 0.75
148 A novel mutation of intron 22 in Janus kinase 3-deficient severe combined immunodeficiency. J Allergy Clin Immunol 2007 0.75
149 A focus on the asthma HEDIS measure and its implications for clinical practice. Manag Care Interface 2006 0.75
150 Effect of the inhaled corticosteroid mometasone on small airway patency in patients with asthma. Allergy Asthma Proc 2009 0.75
151 Introduction. Int Immunopharmacol 2005 0.75
152 Corrigendum: Germline hypomorphic CARD11 mutations in severe atopic disease. Nat Genet 2017 0.75